(Q34183577)

31 July 2017

1 reference

title

Correlations of growth hormone (GH) and insulin-like growth factor I (IGF-I): effects of exercise and abuse by athletes (English)

1 reference

31 July 2017

1 reference

De Palo EF

1

1 reference

31 July 2017

Gatti R

2

1 reference

31 July 2017

Lancerin F

3

1 reference

31 July 2017

Cappellin E

4

1 reference

31 July 2017

Spinella P

5

1 reference

31 July 2017

1 March 2001

1 reference

31 July 2017

1 reference

31 July 2017

305

1 reference

31 July 2017

1-2

1 reference

31 July 2017

1-17

1 reference

Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Growth hormone and exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Effects of growth hormone replacement on physical performance and body composition in GH deficient adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Suppression of the nocturnal rise in growth hormone reduces subsequent lipolysis in subcutaneous adipose tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

The role of receptor dimerization domain residues in growth hormone signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Growth hormone receptor and serum binding protein: purification, cloning and expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Regulation of human growth hormone receptor gene transcription by human growth hormone binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Voluntary exercise training enhances glucose transport in muscle stimulated by insulin-like growth factor I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Diurnal variation in serum insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH-deficient adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Growth Hormone Heterogeneity: Genes, Isohormones, Variants, and Binding Proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Growth hormone heterogeneity in human pituitary and plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Physical fitness, endurance training, and the growth hormone-insulin-like growth factor I system in adolescent females

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Insulin-like growth factors (IGF-I, free IGF-I, and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults: I. Effects on insulin-like growth factor-I (IGF-I), GH and IGF binding proteins, and glucose homeostasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Circulating levels of human insulin-like growth factor binding protein-6 (IGFBP-6) in health and disease as determined by radioimmunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Detection of doping with human growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Serum concentrations of insulin, insulin-like growth factor(IGF)-I, IGF binding protein (IGFBP)-1 and -3 and growth hormone binding protein in obese children: fasting IGFBP-1 is suppressed in normoinsulinaemic obese children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Serum IGF-I and IGF binding proteins 2 and 3 as potential markers of doping with human GH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Infradian rhythms in urinary growth hormone excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Influence of exercise duration on serum insulin-like growth factor and its binding proteins in athletes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Urinary growth hormone following exercise to assess growth hormone production in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

The hormonal response to exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Growth Hormone and Insulin-Like Growth Factor I Responses to Moderate Submaximal Acute Physical Exercise in Man: Effects of Octreotide, a Somatostatin Analogue, Administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Plasma insulin-like growth factor-I and high affinity growth hormone-binding protein levels increase after two weeks of strenuous physical training.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Effect of training and growth hormone suppression on insulin-like growth factor I mRNA in young rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Effects of gender on exercise-induced growth hormone release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Influence of physical activity on plasma insulin-like growth factor-1 and insulin-like growth factor binding proteins in healthy older women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Effects of heavy-resistance training on hormonal response patterns in younger vs. older men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Development and evaluation of a direct immunofluorimetric assay for urinary growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Detection of human growth hormone doping in urine: out of competition tests are necessary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Serum levels of 20-kilodalton human growth hormone (GH) are parallel those of 22-kilodalton human GH in normal and short children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Generation, characterization and utilization of anti-human growth hormone 1-43, (hGH1-43), monoclonal antibodies in an ELISA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

A recombinant-DNA-derived modification of human growth hormone (hGH44-191) with enhanced diabetogenic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

Isotopic differences in human growth hormone preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

The future of doping control in athletes. Issues related to blood sampling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900378-3

10.1016/S0009-8981(01)00378-3

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference